NIH Common Fund Data Ecosystem (CFDE) FAIR Rubric
A rubric for evaluating the FAIRness of NIH-CFDE Resources
Tags: nihcommonfund
URL(s):
View AssociationsRubric Assessments (626384)
| Assessment | Metrics | Date | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Target | Project | Contact information is provided for the creator(s) of the dataset. | Globally unique identifier | Machine-readable metadata | Standardized metadata | Resource identifier in metadata | Open, Free, Standardized Access protocol | Digital resource license | Metadata license | NIH program name is available for querying | NIH project name is available for querying | The institution that created this dataset is available | A biological assay is present and resolvable in CFDE-specified ontology (OBI) | A relevant anatomical part is present and resolvable in the UBERON Ontology | A relevant disease is present and resolvable in the MONDO Ontology | A relevant file type is present and resolvable in the EDAM Ontology | A relevant taxonomy is present and resolvable in the NCBITaxon Ontology | A relevant cell line is present and resolvable in the Cellosaurus Ontology | A landing page exists and is accessible | ||
| Normal plasma cells,Low proliferation multiple myeloma and High proliferation multiple myeloma cells | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| 1H NMR Metabolomics Study of Metastatic Melanoma in C57BL/6J Mouse Spleen | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Placental cells (BeWo) phthalate exposure metabolomics | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Human NK vs T cell metabolism using 13C-Glucose tracer with/out galactose (part II) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Metabolomics Involved in Early Life Antibiotic Exposures(TranSTAT-Liver) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Integrated metabolome and transcriptome analyses provide novel insight into colon cancer modulation by the gut microbiota | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| The Influence of Sugar, Artificial Sweeteners, and the Microbiome on Rodent Amino Acids (part IV) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | no (0.00) | yes (1.00) | yesbut (0.75) | no (0.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | Sep 23, 2019 | |
| IWMS Study 1:Weight comparison of obese and lean patients | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Metabolic effects of novel aldehyde dehydrogenase inhibitors (ALDH) inhibitors | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Lipidomics analysis for aged mice femoral muscle (part - IV) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | no (0.00) | yes (1.00) | yesbut (0.75) | no (0.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | Sep 23, 2019 | |
| Activity-Based Metabolic Profiling of M. tuberculosis H37Rv Rv3722c | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Perinatal DDT causes dysfunctional lipid metabolism underlying metabolic syndrome | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Plasma Nucleotide/adenosine concentrations (Human AxP Batch 3) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| GBM Cell Lines Reproducibility Pilot Study | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Amino Acd Metabolites of Dietary Salt Effects on Blood Pressure in Human Urine from 20 Participants of the DASH2 Clinical Trial (part II) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Exposure to high fat diets and bisphenol | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Vitamin B6 Effects on one-carbon metabolism | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer (training set) | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Distinctly perturbed metabolic networks underlie differential tumor tissue damages induced by immune modulator b-glucan in a two-case ex vivo non-small cell lung cancer study | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Experiment HuA: Metabolomics of plasma samples from humans infected with Plasmodium vivax strain. | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Metabolic heterogeneity in Glioblastoma | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Metabolites produced by strains associated with inflammation | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Assessment of dietary zinc on SCFA cecal production | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
| Non-targeted Metabolomics Analysis of Golden Retriever Muscular Dystrophy-Affected Muscles Reveals Alterations in Arginine and Proline Metabolism, and Elevations in Glutamic and Oleic Acid In Vivo | Metabolomics: FAIR Assessment of NIH Common Fund Resources with C2M2 |
|
maybe (0.50) | no (0.00) | yes (1.00) | yesbut (0.75) | yes (1.00) | no (0.00) | yes (1.00) | no (0.00) | yes (1.00) | yesbut (0.75) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Sep 23, 2019 | |
